| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.053 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |